Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

Scientists have identified a rare genetic mutation in ITSN1 that increases the risk of Parkinson’s disease by up to tenfold, ...

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...

Zhittya Genesis Medicine proudly announces that Dr. Jack Jacobs, President and Chief Science Officer, will be honored by NevadaBio at its Annual Awards Dinner on Wednesday, April 2, 2025, at 5:30 pm ...

led by an international team of researchers at Baylor College of Medicine, AstraZeneca and the Jan and Dan Duncan ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

In the future, therapies that focus on gut health—whether through diet, medication, or nerve stimulation—could be used to ...

New research suggests that dancing might lighten the depression suffered by many people with Parkinson’s disease, an approach ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behavior or ...

“Zhittya Genesis Medicine was founded on the principle ... from NevadaBio not only celebrates our achievements in reversing Parkinson’s disease symptoms in hundreds of patients, but also ...